Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-019208
Filing Date
2025-02-12
Accepted
2025-02-12 20:15:11
Documents
2
Period of Report
2025-01-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6504
2 EX-24 ffntf-ex24.htm EX-24 20669
  Complete submission text file 0000950170-25-019208.txt   28590
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Issuer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address C/O 4FRONT VENTURES 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address
Kronberg Michael (Reporting) CIK: 0002055505 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-56075 | Film No.: 25616778